Concepedia

Chantal Masungi

CM

Statistics

Publications

9

Citations

641

H-Index

9

Active since

2002

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (United States)

Johnson & Johnson (Brazil)

Chantal Masungi is an author at Janssen (Belgium) specializing in pharmacy, pharmacology, and life sciences.

Publications per year

2002–2014

9

Publications

9

Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories

Rose Hayeshi, Constanze Hilgendorf, Per Artursson et al. · European Journal of Pharmaceutical Sciences · 2008 · 264 citations

Life Sciences, Molecular Biology, Pharmacology +14

Differential T and B Cell Responses against<i>Mycobacterium tuberculosis</i>Heparin‐Binding Hemagglutinin Adhesin in Infected Healthy Individuals and Patients with Tuberculosis

Chantal Masungi, Stéphane Temmerman, Jean‐Paul Van Vooren et al. · The Journal of Infectious Diseases · 2002 · 114 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains

Céline Mordant, Benoît Schmitt, Élisabeth Pasquier et al. · European Journal of Medicinal Chemistry · 2006 · 70 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators

François Bischoff, Didier Berthelot, Michel De Cleyn et al. · Journal of Medicinal Chemistry · 2012 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Parallel Artificial Membrane Permeability Assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates

Chantal Masungi, J. Mensch, A. Van Dijck et al. · Die Pharmazie · 2008 · 47 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 9